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Editor’s key points
† Major surgery can result in
significant blood loss and
coagulopathy in children
requiring rapid and accurate
assessment of coagulation
status.
† This observational study
compared standard
coagulation testing to
rotational
thromboelastometry in
children undergoing major
surgery.
† Standard coagulation testing
did not correlate well with
thromboelastometry testing
except for fibrinogen levels
with FibTEM.
† Further studies are needed to
develop thromboelasto-
metry-guided transfusion
guidelines in children.
Background. Thromboelastometry (ROTEMw) might be useful to detect intraoperative
coagulation disorders early in major paediatric surgery. This observational trial compares
this technique to standard coagulation tests.
Methods. Intraoperative blood sampling was obtained in children undergoing elective
major surgery. At each time point, standard coagulation tests [activated partial
thromboplastin time (aPTT), prothrombin time (PT), and fibrinogen level] and ROTEMw
analyses (InTEM, ExTEM, and FibTEM) were performed simultaneously by trained hospital
laboratory staff.
Results. A total of 288 blood samples from 50 subjects were analysed. While there was a
poor correlation between PT and aPTT to ExTEM clotting time (CT) and InTEM CT,
respectively, a good correlation was detected between PT and aPTT to clot formation
time, and a very good correlation between fibrinogen level and FibTEM assay (r¼0.882,
P,0.001). Notably, 64% of PT and 94% of aPTT measurements were outside the
reference range, while impaired CT was observed in 13% and 6.3%, respectively.
Standard coagulation test results were available after a median of 53 min [inter-quartile
range (IQR): 45–63 min], whereas 10 min values of ROTEMw results were available online
after 23 min (IQR: 21–24 min).
Conclusions. PT and aPTT cannot be interchangeably used with ROTEMw CT. Based on the
results of ROTEMw, recommended thresholds for PT and aPTT might overestimate the
need for coagulation therapy. A good correlation was found between the fibrinogen level
and the FibTEM assay. In addition, ROTEMw offered faster turnaround times.
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Major surgical procedures in children are frequently associated
with significant blood loss per kilogram body weight and the
resulting need for transfusion of allogeneic blood products,
which can be further aggravated by development of dilutional
coagulopathy.1 As a result, early detection of signs of coagulo-
pathy is a major issue and challenge for paediatric anaesthe-
tists. Standard coagulation tests [prothrombin time (PT),
activated partial thromboplastin time (aPTT), and plasma fibri-
nogen level] in the perioperative setting are time-consuming,2
3 which delays prompt haemostatic therapy.
Rotation thromboelastometry (ROTEMw, TEMw Inno-
vations, Munich, Germany) offers an alternative approach
to assess perioperative coagulation disorders by means of
visco-elastic analysis of clotting in vitro. First results are
available within 10 min of test initiation, and clot formation
can be observed online by a bedside monitor. The current
recommendations for transfusion of fresh frozen plasma
(FFP) or administration of prothrombin complex concentrates
are mainly based on prolonged PT and aPTT.4 Recently,
results in trauma patients show good results using the
ROTEMw clotting time (CT) instead of PT/aPTT to assess
coagulation status.5 Only limited data comparing the two
approaches are available.
The aims of the current clinical observational study were
(i) to compare standard coagulation measurements (PT,
aPTT, and fibrinogen level) with ROTEMw testing and (ii) to
compare the times required for performance of each
method.
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Methods
This prospective observational study project was approved by
the institutional Ethics Committee of University Children’s
Hospital Zurich (KEK StV 27/08). Written informed consent
was obtained from parents. The study was performed in pae-
diatric patients undergoing elective major surgery with a
high likelihood of considerable blood loss and the need for
close intraoperative coagulation testing. Patients were
excluded if preoperative standard coagulation tests or
blood count were abnormal, or any history of hereditary or
acquired coagulopathy including renal, hepatic, and bone
marrow disease were known. No uniform transfusion
protocol was used, as the main focus was the comparison
between both coagulation measurements. Most anaesthe-
tists used classical plasmatic coagulation intervention
guidelines,4 and some of the younger anaesthetists used
ROTEMw to monitor fibrinogen concentration.
Blood samples were obtained at baseline in all subjects
after general anaesthesia was induced and venous or arterial
access was established, and thereafter at the discretion of
the anaesthesiologist in charge during the entire surgical
procedure. At each time point, two 3 ml tubes containing
0.14 ml citrate solution (S-monovettesw, Sarstedt, Nuem-
brecht, Germany) were taken for coagulation and ROTEMw
tests and immediately transported manually to the hospital
central laboratory. All intraoperative measurements were
labelled as urgent on the form that was filled in for our lab-
oratory personnel.
Citrated blood of one tube was analysed after centrifu-
gation at 3000g for 15 min at 188C on a STA Compactw
coagulation analyser (Roche Diagnostics AG, Rotkreuz, Swit-
zerland) to measure PT, aPTT, and fibrinogen. Simul-
taneously, thromboelastometry was performed in the
hospital central laboratory by trained operators using the
ROTEMw device. Technical details of the ROTEMw analyser
have been described elsewhere.6 The CT was defined from
the start of measurement until the initiation of clotting
after 20 ml of a buffered concentrated calcium chloride sol-
ution (StarTEMw reagent) and the activator was added to
the whole blood sample.
To compare measurements of standard coagulation tests
(PT, aPTT, and fibrinogen level), the following corresponding
ROTEMw tests were defined:6
† CT and clot formation time (CFT) of the extrinsically acti-
vated ROTEMw assay (ExTEM CT and CFT, respectively);
activation with 20 ml tissue factor to be compared
with the PT;
† CT and CFT of the intrinsically activated ROTEMw assay
(activation of 20 ml phospholipid–ellagic acid; InTEM
CT and CFT, respectively); to be compared with the aPTT;
† Comparison of the functional fibrinogen test (Clauss
assay) to be compared with the clot firmness after
10 min (FibTEM A10) and to the maximum clot firmness
(FibTEM MCF) of the FibTEM assay. The FibTEM test was
based on an ExTEM assay that also contains the platelet
inhibitor cytochalasin D to separately evaluate func-
tional fibrin polymerization without platelet activity.
In addition, platelet count was correlated to InTEM and
ExTEM maximum clot firmness (MCF) and to the clot ampli-
tude after 10 min (A10).
All devices were set up according to quality standards and
underwent periodic quality controls. Immediately after
results of standard coagulation measurements were avail-
able, the laboratory staff gave a call to the anaesthetist in
charge and this time was noted for comparison of time of
performance. In contrast, the ROTEMw device was connected
to an intranet network that allows online display of the
resulting curves at the anaesthesia monitoring device. The
time was noted when the 10 min results of the ROTEMw
assays were available online (A10 values).
The SPSS software package (Version 18.0; SPSS Inc.,
Chicago, IL, USA) was used for statistical analyses. After
testing for Gaussian distribution revealed a non-parametric
distribution of laboratory data, Spearman’s correlation was
used for analysis. Data are presented as median values
with Q1 and Q3 quartiles if not otherwise noted.
Results
A total of 288 intraoperative coagulation analyses were
obtained in 50 subjects undergoing major surgery. Surgical
procedures included craniofacial (n¼23), spine (n¼22),
complex hip (n¼2), or cancer surgery (n¼3). Subject charac-
teristics and intraoperative transfusion requirements are pre-
sented in Table 1.
Overall correlation of the investigated assays and corre-
sponding reference ranges are shown in Figures 1–3. As
the reference ranges for standard coagulation tests and
ROTEMw measurements are slightly different for each pae-
diatric age group, we used a calculated mean value for dis-
played reference ranges in Figures 1–3 based on previous
published data.7 8
PT showed a poor correlation to the CT of the extrinsically
activated ROTEMw assay (ExTEM CT) (r¼20.460, P,0.001),
but a high correlation to the CFT (ExTEM CFT; r¼20.782,
P,0.001).
A slightly higher correlation was detected between results
of activated partial thromboplastin time (aPTT) and CT and
CFT of the intrinsically activated ROTEMw test (InTEM),
r¼0.723 (P,0.001) and r¼27.89 (P,0.001), respectively.
Surprisingly, 94% of all aPTT values were outside the refer-
ence range, and according to the current guidelines, in
52%, prolongation of aPTT was designated to be clinically
meaningful (.45 s). In contrast, increase in InTEM CT was
only detected in 18 out of 285 analyses (6.3%). Since no con-
clusive threshold for CT has been published and validated, we
defined CT values outside the normal range as abnormal.
The overall correlation of PT and ExTEM CT and of aPTT and
InTEM CT was not significantly higher if only levels within the
reference ranges were compared (calculations not shown).
Measurements of the functional fibrinogen tests using the
Clauss assay and ROTEMw FibTEM A10 and MCF showed a
Comparison of ROTEM vs standard laboratory testing BJA
37
high overall correlation (r¼0.823, P,0.001 and r¼0.882,
P,0.001). Both assays revealed impaired fibrin polymeriz-
ation (FibTEM MCF ,7 mm) and diminished plasma fibrino-
gen levels (Clauss assay ,1.8 g litre21) in about 33% of all
intraoperative coagulation analyses.
Clot amplitude A10 and MCF showed a high correlation to
platelet count in the InTEM assay (r¼0.9, P,0.001 and
r¼0.873, P,0.001, respectively) as well as in the ExTEM
test (r¼0.860, P,0.001 and r¼0.77, P,0.001, respectively).
Results of standard coagulation measurements were
transmitted immediately by phone call from the central
laboratory which took a median of 53 min [inter-quartile
range (IQR): 45–63 min] after blood sampling, whereas 10
min values of ROTEMw (A10) were available online after 23
min (IQR: 21–24 min).
Discussion
A major finding of this study is that only a moderate corre-
lation exists between standard coagulation tests such as PT
Table 1 Subject characteristics (n¼50) and description of
intraoperative transfusion therapy. Data are expressed as median
(IQR) or number, as appropriate
Subject characteristics and intraoperative course
Age (yr) 3.2 (0.8–10.7)
Gender (female/male) 24/26
Height (cm) 87.2 (72.2–118)
Weight (kg) 13.0 (9.0–22.5)
Total amount of infused crystalloids and colloids
(ml kg21)
128 (94.1–167)
Transfusion of RBC (ml kg21) (in 44 out of 50
patients)
40.0 (20.8–65.1)
Transfusion of FFP (ml kg21) (in 24 out of 50
patients)
21.9 (11.1–32.3)
Transfusion of platelets (ml kg21) (in 8 out of 50
patients)
16.7 (12.6–26.6)
Administration of human fibrinogen
concentrate (mg kg21) (in 37 out of 50 patients)
44.5 (16.2–77.0)
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or aPTT compared with the CTs using the extrinsically or
intrinsically activated ROTEMw tests. Similar findings of only
modest correlation are supported by results of other study
groups.7 9 10 Therefore, results of CT in ROTEMw tests and
results of PT or aPTT cannot be used interchangeably for
detecting intraoperative haemostatic disorders.
While impaired CT values were observed in only X% (37
out of 285 samples), more than 64% of PT measurements
were outside the reference range (185 out of 288). PT
values below a threshold of 50 s were observed in 22.6%.
Impaired activation of the extrinsic pathway was uniformly
detected with both assays in 37 out of 288 samples (13%).
Even more surprisingly, 94% of all aPTT values were outside
the reference range; and according to the current guidelines,
in 52%, prolongation of aPTT levels was classified as clinically
meaningful (.45 s).11 In contrast, increase in InTEM CT was
only detected in 18 out of 285 analyses (6.3%). This differ-
ence between tests might be explained by the fact that stan-
dard coagulation tests are performed in plasma while
ROTEMw tests use whole blood. Apart from that, PT/aPTT
measurements depend on the reagents used, incubation
time, and the method of endpoint detection and show con-
siderable variability between laboratories.
Tripodi and colleagues12 stated that standard coagulation
tests failed to reflect the balance between the actions of pro-
and anticoagulant factors. Another aspect is that children in
our study experienced different stages of dilutional coagulo-
pathy, which is likely to be differently displayed by various
coagulation measurements.
Notably, InTEM and ExTEM CFT showed a fairly high corre-
lation to aPTT and PT, respectively. This was in accordance
with the results from adult trauma patients that showed
an excellent correlation between InTEM CFT and aPTT
(r¼0.91), while correlation between InTEM CT and aPTT was
rather poor (r¼0.47).9 Despite a good correlation between
clot strength after 15 min (ExTEM CA15) and PT in that inves-
tigation, the question of the optimal threshold for laboratory
coagulation testing and ROTEMw measurements that reliably
guides adequate haemostatic therapy remains. Recommen-
dations of critical thresholds for PT and aPTT in current guide-
lines were based largely on expert opinion and sparse
publications of clinical studies.13 – 15 The PT or aPTT tests
have been shown to overestimate the underlying coagulation
factor activity if more than one factor is reduced,16 which
typically occurs in dilutional coagulopathy. Thus, impaired
aPTT or PT values are a very common and early finding
during intraoperative bleeding and haemodilution.15 17 If
these early abnormalities are not linked to relevant increase
in bleeding, this might lead to considerable over-transfusion
of FFP and other blood products. In adult liver transplan-
tation, Wang and colleagues18 showed a significant decrease
in transfused allogeneic blood products following a transfu-
sion algorithm using ROTEMw compared with standard lab-
oratory tests. Data from Scho¨chl and colleagues revealed
the effective use of ROTEMw-guided coagulation manage-
ment in trauma patients by reducing the amount of allo-
geneic blood product transfusion.5 However, there is a lack
of data proving the usefulness of ROTEMw-guided coagu-
lation management in children.19 20
Clot firmness analysed A10 or at maximum levels showed
a very good correlation to platelet count. This finding is sup-
ported by data from liver transplantation in adults providing
similar results (r¼0.779, P,0.001).21 Thus, MCF or even A10
values might serve as surrogate parameters to estimate
platelet function.
Fibrinogen/fibrin is an important contributor to clot
strength and is the first coagulation factor to become criti-
cally reduced during perioperative haemorrhage and dilu-
tional coagulopathy.17 22 23 In our study, plasma fibrinogen
level assessed with the Clauss assay showed a high to a
very high correlation to the FibTEM A10 and MCF. This
finding is supported by other studies showing similar good
correlations.9 24 Impaired functional fibrinogen levels were
observed in our study considerably more frequently based
on the Clauss assay (54%), while the FiBTEM MCF showed
impaired values in 37% of test results. Severe deterioration
of plasma fibrinogen levels below 1.0 g litre21 were observed
in 11%. Although a minimum level of plasma fibrinogen of
1 g litre21 was recommended by older guidelines4 25, there
is growing evidence that considerably higher fibrinogen
levels (.1.5–2 g litre21) are necessary to control bleed-
ing.26 – 31 However, no universal threshold for minimum fibri-
nogen levels is supported by evidence-based data, and this
could depend on other factors such as the type of surgery
or concomitant coagulation factor activities. Another mean-
ingful limitation of the Clauss assay is that fibrinogen levels
can be considerably altered after massive fluid resuscitation
and that colloids can induce erroneously increased levels of
fibrinogen when using the photometric Clauss method.28 32
Recently published data suggest that the mechanical detec-
tion principle of fibrinogen testing is more reliable than
photometric techniques.33
Overall, there was a clear advantage for ROTEMw com-
pared with standard coagulation tests in their shorter turn-
around times, which will have an impact on timely and
more targeted coagulation therapy.19 24 28 34 35 Although
point-of-care testing devices for the measurement of PT
and aPTT might improve the time delay of standard labora-
tory testing, the other limitations of standard testing in the
perioperative setting were still valid.
Some limitations in our study design need to be men-
tioned. First, ROTEMw analyses were performed not as
bedside tests but in a central laboratory with a certain time
delay for sample transport. However, previous studies using
the ROTEMw have shown that blood samples remain stable
over time.36 Secondly, gelatin solution was exclusively used
for fluid resuscitation in the majority of children, but not fol-
lowing a uniform strategy; thus, it was not possible to dis-
tinguish the impact on coagulation measurements from
other causes for coagulopathy. Finally, this study was not
designed to compare laboratory findings with clinical signs
of increased bleeding. As a matter of course, transfusion
therapy was not solely based on laboratory findings but
additionally related to clinical observations. Difficulties in
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distinguishing surgical from coagulopathic bleeding might
increase the likelihood of more liberal transfusion regimens.
Furthermore, a normal ROTEMw trace showed a high negative
predictive value and might identify surgical bleeding early by
distinguishing it from coagulopathic bleeding.37 More effort
to evaluate and standardize intraoperative visual assessment
of coagulopathic bleeding in combination with coagulation
measurements is required.
In conclusion, PT and aPTT cannot be used interchange-
ably to predict ROTEMw CT. Based on the results of ROTEMw
testing, the currently recommended thresholds for PT and
aPTT might overestimate the need for coagulation therapy.
A good correlation was found between fibrinogen levels
and the FibTEM assay. In addition, ROTEMw offers faster turn-
around times, which can impact on timely monitoring and
guiding coagulation therapy.
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